Australia: Icahn School of Medicine at Mount Sinai Receives Patent for 'Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis'

Media coverage

• Title	Australia: Icahn School of Medicine at Mount Sinai Receives Patent for 'Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis'
  Media name/outlet	Australian Government News (Ht Media)
  Country/Territory	Australia
  Date	26/06/20
  Persons	Adam S. Morgenthau